News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() National Lymphedema Network 12th International Conference to Draw Hundreds to Share KnowledgeThe NLN International Conference is designed to share knowledge from every facet of medical and patient communities to serve the hundreds of thousands of lymphedema patients that often go under-served or misdiagnosed.
Lymphedema is a chronic swelling caused by damage or removal of lymph vessels, often during surgery or cancer treatment, (secondary lymphedema) but can also be hereditary (primary lymphedema). Patients often find it difficult to obtain diagnosis and referral to proper treatment by a Certified Lymphedema Therapist (CLT). “Our theme for the 2016 Conference in Dallas is ‘Shaping the Future through Commitment, Evidence and New Frontiers,’” said NLN Board Chair Patricia Egan, “NLN conferences continue to present ground-breaking research from throughout the world in a forum designed to foster new discussion and exchange between the leading organizations and professionals that are guiding the lymphedema patient and medical community into the future.” The 12th NLN International Conference will bring together Certified Lymphedema Therapists, doctors, surgeons, patient advocates and other lymphedema professionals for a robust program consisting of instructional and plenary sessions, an exhibit hall featuring leading industry representatives and presentations, poster sessions, networking events, the Lymph Science Advocacy Program (LSAP) for patients, and four pre-conference instructional seminars. Early Bird-discount registration for Conference, Exhibitor, and LSAP registration as well as Preliminary Program are available online at www.lymphnet.org/ The National Lymphedema Network (NLN) is an internationally recognized non-profit organization founded in 1988 by Saskia R.J. Thiadens, RN, to provide education and guidance to lymphedema patients, healthcare professionals and the general public by disseminating information on the risk reduction and management of primary and secondary lymphedema. www.lymphnet.org End
|
|